Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92484965 | 9248496 | 5 | F | 2004 | 20160628 | 20130423 | 20160701 | EXP | US-009507513-1304USA010626 | MERCK | 0.00 | M | Y | 0.00000 | 20160701 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92484965 | 9248496 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||||
| 92484965 | 9248496 | 2 | SS | PROPECIA | FINASTERIDE | 1 | 20788 | FILM-COATED TABLET | |||||||||||
| 92484965 | 9248496 | 3 | SS | PROSCAR | FINASTERIDE | 1 | Oral | UNK | U | 0 | FILM-COATED TABLET | ||||||||
| 92484965 | 9248496 | 4 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 1 MG, QD | U | U | 0 | 1 | MG | QD | |||||
| 92484965 | 9248496 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 92484965 | 9248496 | 6 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 92484965 | 9248496 | 7 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92484965 | 9248496 | 1 | Androgenetic alopecia |
| 92484965 | 9248496 | 2 | Alopecia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92484965 | 9248496 | OT |
| 92484965 | 9248496 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92484965 | 9248496 | Abdominal distension | |
| 92484965 | 9248496 | Adverse event | |
| 92484965 | 9248496 | Anxiety | |
| 92484965 | 9248496 | Asthma | |
| 92484965 | 9248496 | Chest pain | |
| 92484965 | 9248496 | Cognitive disorder | |
| 92484965 | 9248496 | Depression | |
| 92484965 | 9248496 | Erectile dysfunction | |
| 92484965 | 9248496 | Gastrooesophageal reflux disease | |
| 92484965 | 9248496 | Hypercholesterolaemia | |
| 92484965 | 9248496 | Hypertension | |
| 92484965 | 9248496 | Loss of libido | |
| 92484965 | 9248496 | Nephrectomy | |
| 92484965 | 9248496 | Prostatitis | |
| 92484965 | 9248496 | Sexual dysfunction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92484965 | 9248496 | 1 | 2008 | 2012 | 0 | |
| 92484965 | 9248496 | 4 | 20130514 | 20150409 | 0 | |
| 92484965 | 9248496 | 5 | 2004 | 0 | ||
| 92484965 | 9248496 | 6 | 2004 | 0 | ||
| 92484965 | 9248496 | 7 | 2004 | 0 |